SpineTop Stories

CTL Amedica to unveil MONET™ Integrated ACIF Cage System during NASS Sept. 25 – 28


CTL Amedica Corporation will officially launch its MONET™ ACIF Integrated Cage System with Supplementary Fixation during the North American Spine Society (NASS) annual meeting and exhibition Sept. 25-28, 2019. NASS will be held at McCormick Place, West Building, located at 2301 S. King Drive in Chicago, IL. CTL Amedica representatives will be available in booth 2627 to answer questions about MONET™ and the full line of CTL Amedica products.

The MONET™ is an FDA-approved, integrated anterior cervical fusion system, designed with patients in mind. It features streamlined instrumentation, cage material offerings in both titanium and PEEK, and anterior plating in low-profile, four-screw and zero-profile, two-screw configurations. This provides surgeons with a variety of construct options and allows true intra-operative flexibility.

“The MONET™ enables greater flexibility during anterior cervical spine surgery, which can help surgeons to better serve their patients’ individual needs,” says Daniel Chon, CTL Amedica president and CEO. “We’ve been working on the product for quite some time and received FDA approval to market it several months ago. We’re excited to officially unveil it to the spine community at NASS.”

NASS is the largest spine meeting and exhibition worldwide. The North American Spine Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. For more information, visit http://www.spine.org.

CTL Amedica Corporation is a medical device company headquartered in Dallas that designs, develops and manufactures spinal implants and instruments that are tailored to fit the unique needs of both surgeons and patients. It maintains an in-house manufacturing facility and an R&D Center of Excellence, and it provides a full line of cervical, thoracic and lumbar products. It also is the world’s exclusive provider of silicon nitride spine products. Silicon nitride demonstrates unique bacteriostatic properties, provides superior imaging across all modalities and fosters an enhanced osteogenic response. For more information, visit https://www.ctlamedica.com/.

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button